Tianjin Pharmaceutical
Tianjin Pharmaceutical Group Co., Ltd., commonly referred to as Tianjin Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and innovative formulations. With a strong presence in both domestic and international markets, Tianjin Pharmaceutical is recognised for its commitment to quality and research-driven solutions. The company’s core offerings, which include a variety of therapeutic agents, are distinguished by their adherence to stringent quality standards and advanced production techniques. Over the years, Tianjin Pharmaceutical has achieved notable milestones, solidifying its position as a trusted name in healthcare and contributing to the global pharmaceutical landscape.
DitchCarbon Score
How does Tianjin Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianjin Pharmaceutical's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tianjin Pharmaceutical's reported carbon emissions
In 2023, Tianjin Pharmaceutical reported total carbon emissions of approximately 37,390,947 kg CO2e. This figure includes Scope 1 emissions of about 5,901,710 kg CO2e and Scope 2 emissions of approximately 19,457,087 kg CO2e, primarily from purchased electricity and heat. Notably, there were no reported Scope 3 emissions. Despite the significant total emissions, Tianjin Pharmaceutical has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of climate pledges or commitments suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Tianjin Pharmaceutical's future commitments will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 5,901,710 |
| Scope 2 | 19,457,087 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tianjin Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
